Trial Profile
A Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2020
Price :
$35
*
At a glance
- Drugs Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors GE Healthcare
- 19 Oct 2020 Results evaluating novel Ab-PET based quantitative measure using data from four trials (NCT01208675, NCT00106899, NCT01165554 and NCT02090855) published in the Neurology
- 26 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Apr 2014 New trial record